Chantal Lutfallah
Pediatric Endocrinology · Baton Rouge, LANPI 1376534131
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $673 and has fallen 96.3% since, to $25 in 2024.
Across 104 payments — averaging $20.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$379
- Medtronic$228
- AstraZeneca$220
- Abbott$173
- AbbVie$163
- Xeris Pharmaceuticals, Inc.$123
- plus $878 from 21 others
What the payments were for
- Food & beverage$2,09597%
- Education$683%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 19 | $379 |
| Medtronic(2 entities) | 16 | $228 |
| AstraZeneca(2 entities) | 4 | $220 |
| Abbott | 4 | $173 |
| AbbVie | 9 | $163 |
| Xeris Pharmaceuticals, Inc. | 6 | $123 |
| Biomarin Pharmaceutical Inc. | 3 | $84 |
| Lilly USA, LLC | 5 | $82 |
| Novo Nordisk | 4 | $81 |
| Endo Pharmaceuticals Inc. | 5 | $76 |
| Tolmar Pharmaceuticals, Inc. | 4 | $73 |
| Grifols USA, LLC | 3 | $65 |
| Ultragenyx Pharmaceutical Inc. | 4 | $58 |
| Arbor Pharmaceuticals, Inc. | 3 | $53 |
| Ascendis Pharma Endocrinology Inc | 2 | $43 |
| Pfizer | 2 | $40 |
| Stimwave Technologies Incorporated | 1 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Zealand Pharma US, Inc. | 1 | $19 |
| CSL Behring | 1 | $18 |
| Tandem Diabetes Care, Inc. | 1 | $17 |
| Cumberland Pharmaceuticals, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Insulet Corporation | 1 | $14 |
| BD | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Strensiq$172
- FreeStyle Libre Pro$125
How this compares
Too few pediatric endocrinology providers in Louisianato place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in Baton Rouge
- James GardnerBaton Rouge$2K
- Marcela Astudillo JarrinBaton Rouge$1K
- Manish RaisinganiBaton Rouge$957
- Stuart ChalewNew Orleans$7K
- Ricardo GomezNew Orleans$6K
- Janna Flint WilsonLafayette$5K
- Cielo AlleynNew Orleans$3K
- Dania Felipe-RamirezNew Orleans$3K
- Sasi PenukondaShreveport$2K
- Arlette Soros DupreNew Orleans$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.